HAEM5:Plasma cell myeloma / multiple myeloma: Difference between revisions
| [pending revision] | [pending revision] |
Zhenya.Tang (talk | contribs) |
Zhenya.Tang (talk | contribs) No edit summary |
||
| Line 18: | Line 18: | ||
*Zhenya Tang, MD, PhD<sup>2</sup> | *Zhenya Tang, MD, PhD<sup>2</sup> | ||
<sup>1</sup>The University of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas | <sup>1</sup> The University of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas | ||
2 University of Nebraska Medical Center, Department of Pathology, Microbiology and Immunology, Omaha, Nebraska | <sup>2</sup> University of Nebraska Medical Center, Department of Pathology, Microbiology and Immunology, Omaha, Nebraska | ||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||